US Bancorp’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274M Sell
1,012,177
-27,701
-3% -$8.25M 0.33% 66
2025
Q4
$343M Buy
1,039,878
+14,005
+1% +$4.75M 0.4% 51
2025
Q3
$354M Sell
1,025,873
-14,771
-1% -$4.47M 0.42% 50
2025
Q2
$325M Sell
1,040,644
-54,113
-5% -$20.7M 0.41% 54
2025
Q1
$573M Sell
1,094,757
-24,633
-2% -$12.6M 0.77% 27
2024
Q4
$566M Buy
1,119,390
+64
+0% +$36.4K 0.74% 28
2024
Q3
$654M Sell
1,119,326
-5,171
-0.5% -$2.92M 0.84% 23
2024
Q2
$573M Buy
1,124,497
+5,342
+0.5% +$2.62M 0.78% 24
2024
Q1
$554M Buy
1,119,155
+26,473
+2% +$13.5M 0.77% 26
2023
Q4
$575M Sell
1,092,682
-20,089
-2% -$10.7M 0.85% 20
2023
Q3
$552M Buy
1,112,771
+14,408
+1% +$7.09M 0.9% 19
2023
Q2
$528M Sell
1,098,363
-5,797
-0.5% -$2.83M 0.85% 20
2023
Q1
$522M Sell
1,104,160
-24,224
-2% -$11.7M 0.88% 23
2022
Q4
$598M Buy
1,128,384
+62,880
+6% +$33.3M 1.06% 16
2022
Q3
$538M Sell
1,065,504
-9,391
-0.9% -$4.94M 1.11% 13
2022
Q2
$552M Buy
1,074,895
+3,454
+0.3% +$1.73M 1.07% 17
2022
Q1
$546M Buy
1,071,441
+4,134
+0.4% +$1.99M 0.91% 22
2021
Q4
$536M Sell
1,067,307
-33
-0% -$14.9K 0.85% 24
2021
Q3
$417M Buy
1,067,340
+1,505
+0.1% +$623K 0.78% 26
2021
Q2
$427M Buy
1,065,835
+584
+0.1% +$233K 0.8% 27
2021
Q1
$396M Buy
1,065,251
+4,089
+0.4% +$1.42M 0.8% 25
2020
Q4
$372M Sell
1,061,162
-31,550
-3% -$10.6M 0.8% 25
2020
Q3
$341M Sell
1,092,712
-27,049
-2% -$8.31M 0.83% 22
2020
Q2
$330M Sell
1,119,761
-36,039
-3% -$10.3M 0.87% 24
2020
Q1
$288M Sell
1,155,800
-20,287
-2% -$5.58M 0.9% 24
2019
Q4
$346M Sell
1,176,087
-31,171
-3% -$8.16M 0.88% 24
2019
Q3
$262M Buy
1,207,258
+4,870
+0.4% +$1.18M 0.72% 31
2019
Q2
$293M Buy
1,202,388
+56,956
+5% +$13.7M 0.82% 24
2019
Q1
$283M Buy
1,145,432
+28,030
+3% +$7.15M 0.82% 27
2018
Q4
$278M Buy
1,117,402
+6,467
+0.6% +$1.71M 0.9% 21
2018
Q3
$296M Buy
1,110,935
+261
+0% +$67.9K 0.86% 20
2018
Q2
$272M Sell
1,110,674
-4,540
-0.4% -$1.09M 0.83% 22
2018
Q1
$239M Sell
1,115,214
-177
-0% -$40.4K 0.73% 29
2017
Q4
$246M Sell
1,115,391
-35,170
-3% -$7.45M 0.75% 26
2017
Q3
$225M Buy
1,150,561
+58,690
+5% +$11.3M 0.72% 27
2017
Q2
$202M Buy
1,091,871
+26,719
+3% +$4.69M 0.68% 30
2017
Q1
$175M Sell
1,065,152
-9,761
-0.9% -$1.6M 0.6% 35
2016
Q4
$172M Buy
1,074,913
+15,324
+1% +$2.29M 0.62% 33
2016
Q3
$148M Buy
1,059,589
+41,785
+4% +$5.85M 0.55% 37
2016
Q2
$144M Buy
1,017,804
+35,590
+4% +$4.75M 0.55% 40
2016
Q1
$127M Buy
982,214
+36,448
+4% +$4.31M 0.5% 48
2015
Q4
$111M Buy
945,766
+1,912
+0.2% +$223K 0.45% 52
2015
Q3
$109M Buy
943,854
+14,233
+2% +$1.7M 0.46% 55
2015
Q2
$113M Sell
929,621
-6,463
-0.7% -$765K 0.44% 53
2015
Q1
$111M Buy
936,084
+48,677
+5% +$5.41M 0.43% 56
2014
Q4
$89.7M Buy
887,407
+23,760
+3% +$2.25M 0.35% 65
2014
Q3
$74.5M Sell
863,647
-6,395
-0.7% -$540K 0.3% 73
2014
Q2
$71.1M Sell
870,042
-20,178
-2% -$1.59M 0.28% 81
2014
Q1
$73M Sell
890,220
-43,899
-5% -$3.3M 0.3% 73
2013
Q4
$70.3M Sell
934,119
-791
-0.1% -$56.8K 0.29% 76
2013
Q3
$66.9M Buy
934,910
+45,558
+5% +$3.26M 0.3% 75
2013
Q2
$58.2M Buy
+889,352
New +$55.3M 0.27% 80

Other funds holding UNH

US Bancorp's UNH Position: Q1 2026 in Review

US Bancorp reduced its UnitedHealth (UNH) stake by 2.7% in Q1 2026, selling an estimated $8.25M and leaving 1,012,177 shares worth $274M. The position accounts for 0.33% of the portfolio, ranked #66.

US Bancorp first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $654M in Q3 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • US Bancorp held 1,012,177 shares of UnitedHealth worth $274M as of Q1 2026.
  • US Bancorp sold 27,701 UnitedHealth shares in Q1 2026, an estimated $8.25M.
  • UnitedHealth made up 0.33% of US Bancorp's portfolio in Q1 2026, its #66 holding.
  • US Bancorp first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's UnitedHealth position peaked at $654M in Q3 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.